oprah semaglutide special Winfrey opens up about recent weight loss Oprah special covering GLP-1s :

Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J

The metabolic and ecological interactions of oxalate-degrading bacteria in the Mammalian gut

Results here will determine whether retatrutide can pursue a combined obesity-and-diabetes indication on its label, which matters commercially: diabetes coverage by Medicare and most commercial insurers is substantially broader than obesity-only coverage

ARPA-H and BARDA should fund a dedicated scale-up program for enzymatic synthesis platforms at U.S

Lab and/or medical tests (such as kidney function, fasting blood glucose, hemoglobin A1c) should be done while you are taking this medication

With rigorous science, responsible claims, and thoughtful communication, this innovation could pave the way for a new class of products that deliver measurable health benefits